Chemokines and their receptors: predictors of the therapeutic potential of mesenchymal stromal cellsNerea Cuesta‐Gomez, John Campbell|Journal of Translational Medicine|2021Cited by 65
Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trialPaul Brennan, Stuart J. Forbes, Iain Macpherson et al.|Nature Medicine|2025Cited by 47
Study protocol: a multicentre, open-label, parallel-group, phase 2, randomised controlled trial of autologous macrophage therapy for liver cirrhosis (MATCH)Paul Brennan, Stuart J. Forbes, Mark T. Macmillan et al.|BMJ Open|2021Cited by 45